BCM
BIOA

Bridgeway Capital Management’s BioAge Labs BIOA Stock Holding History

Bridgeway Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
42,000
-15,600
-27% -$282K 0.02% 736
2026
Q1 		$1.01M Sell
57,600
-20,000
-26% -$385K 0.02% 704
2025
Q4 		$1.03M Buy
77,600
+25,000
+48% +$222K 0.02% 698
2025
Q3 		$309K Hold
52,600
– – 0.01% 919
2025
Q2 		$217K Buy
+52,600
New +$212K 0.01% 944

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Bridgeway Capital Management's BIOA Position: Q2 2026 in Review

Bridgeway Capital Management reduced its BioAge Labs (BIOA) stake by 27% in Q2 2026, selling an estimated $282K and leaving 42,000 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #736.

Bridgeway Capital Management first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Bridgeway Capital Management held 42,000 shares of BioAge Labs worth $1.03M as of Q2 2026.
  • Bridgeway Capital Management sold 15,600 BioAge Labs shares in Q2 2026, an estimated $282K.
  • BioAge Labs made up 0.02% of Bridgeway Capital Management's portfolio in Q2 2026, its #736 holding.
  • Bridgeway Capital Management first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.